A study published in the journal Cancer Research underscores the importance of the molecular characterization of the metast
A study reveals the biological changes in breast cancer between the primary tumour and metastases
8th “Vi per Vida” charity wine-tasting for cancer research
IRB Barcelona opens brand new laboratory for analysis of genomic 'big data'
BIST awards the first five “Ignite” multidisciplinary projects with 20,000€ each
On Sunday 7 May at 17.00h, the “Vi per Vida” (“Wine for Life” in English) charity organisation run by sommelier Xavier Ayala is holding its 8
Researcher in the field of bioinformatics and genomics Fran Supek (b.
Jean-Pierre Sauvage, Nobel Prize in Chemistry 2016, opened the BIST Founding Conference in front of 300 participants including
The Newspaper Nació Digital interviews Meritxell Rovira, visiting scientist in the Biomedical Genomics Lab at IRB Barcelona, about her research on pancreatic stem cells. The best of biomedical research is that "it is interdisciplinary: chemistry, medicine, and biology... Nobody is good enough to know enough, and that is very fortunate," she stresses.
El Punt AVUI
The local newspaper “El Punt Avui” has included an article about IRB Barcelona's new laboratory for analysis of genomic 'big data', entitled Genome Data Science (aGENDAS).
aGENDAS, headed by Fran Supek, is starting this April and will undertake research in Big Data, a strategic area also for the Barcelona Institute of Science and Technology (BIST).
La Sexta newscast team has covered the research performed by IDIBAPS Biomedical Research Institute and IRB Barcelona scientists on a new strategy to achieve genetically modified viruses that selectively attack tumor cells without affecting healthy tissues.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Felice Alessio Bava
former PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
Quick facts about IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.